IRIS Accounts Production v25.2.0.378 13638972 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 0.010 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136389722023-12-31136389722024-12-31136389722024-01-012024-12-31136389722022-12-31136389722023-01-012023-12-31136389722023-12-3113638972ns15:EnglandWales2024-01-012024-12-3113638972ns14:PoundSterling2024-01-012024-12-3113638972ns10:Director12024-01-012024-12-3113638972ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3113638972ns10:SmallEntities2024-01-012024-12-3113638972ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3113638972ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3113638972ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3113638972ns10:FullAccounts2024-01-012024-12-3113638972ns10:OrdinaryShareClass22024-01-012024-12-3113638972ns10:Director22024-01-012024-12-3113638972ns10:Director32024-01-012024-12-3113638972ns10:CompanySecretary12024-01-012024-12-3113638972ns10:RegisteredOffice2024-01-012024-12-3113638972ns5:CurrentFinancialInstruments2024-12-3113638972ns5:CurrentFinancialInstruments2023-12-3113638972ns5:Non-currentFinancialInstruments2024-12-3113638972ns5:Non-currentFinancialInstruments2023-12-3113638972ns5:ShareCapital2024-12-3113638972ns5:ShareCapital2023-12-3113638972ns5:SharePremium2024-12-3113638972ns5:SharePremium2023-12-3113638972ns5:RetainedEarningsAccumulatedLosses2024-12-3113638972ns5:RetainedEarningsAccumulatedLosses2023-12-3113638972ns5:FurnitureFittings2024-01-012024-12-3113638972ns5:ComputerEquipment2024-01-012024-12-3113638972ns5:PlantMachinery2023-12-3113638972ns5:FurnitureFittings2023-12-3113638972ns5:ComputerEquipment2023-12-3113638972ns5:PlantMachinery2024-01-012024-12-3113638972ns5:PlantMachinery2024-12-3113638972ns5:FurnitureFittings2024-12-3113638972ns5:ComputerEquipment2024-12-3113638972ns5:PlantMachinery2023-12-3113638972ns5:FurnitureFittings2023-12-3113638972ns5:ComputerEquipment2023-12-3113638972ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3113638972ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3113638972ns5:WithinOneYear2024-12-3113638972ns5:WithinOneYear2023-12-3113638972ns5:BetweenOneFiveYears2024-12-3113638972ns5:BetweenOneFiveYears2023-12-3113638972ns5:AllPeriods2024-12-3113638972ns5:AllPeriods2023-12-3113638972ns10:OrdinaryShareClass22024-12-31
REGISTERED NUMBER: 13638972 (England and Wales)
















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

ACT MEDICAL LIMITED

ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


ACT MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: J A Bentley
J Y Bentley
I J McRae





SECRETARY: J Y Bentley





REGISTERED OFFICE: Holywell Building
Holywell Way
LOUGHBOROUGH
Leicestershire
LE11 3UZ





REGISTERED NUMBER: 13638972 (England and Wales)





ACCOUNTANTS: Staffords
Chartered Accountants
Unit 1, Cambridge House
Camboro Business Park
Oakington Road, Girton
CAMBRIDGE
Cambridgeshire
CB3 0QH

ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 9,573 8,669

CURRENT ASSETS
Debtors 5 116,770 67,913
Cash at bank 230,751 600,452
347,521 668,365
CREDITORS
Amounts falling due within one year 6 187,223 34,290
NET CURRENT ASSETS 160,298 634,075
TOTAL ASSETS LESS CURRENT
LIABILITIES

169,871

642,744

CREDITORS
Amounts falling due after more than one
year

7

18,000

18,000
NET ASSETS 151,871 624,744

CAPITAL AND RESERVES
Called up share capital 9 144 144
Share premium 995,886 995,886
Retained earnings (844,159 ) (371,286 )
SHAREHOLDERS' FUNDS 151,871 624,744

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 March 2025 and were signed on its behalf by:





J A Bentley - Director


ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024


1. STATUTORY INFORMATION

ACT Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 33% on cost
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 January 2024 2,548 3,990 5,905 12,443
Additions - 4,402 2,164 6,566
At 31 December 2024 2,548 8,392 8,069 19,009
DEPRECIATION
At 1 January 2024 765 991 2,018 3,774
Charge for year 849 2,299 2,514 5,662
At 31 December 2024 1,614 3,290 4,532 9,436
NET BOOK VALUE
At 31 December 2024 934 5,102 3,537 9,573
At 31 December 2023 1,783 2,999 3,887 8,669

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 116,770 67,913

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 18,903 16,769
Taxation and social security 8,416 6,412
Other creditors 159,904 11,109
187,223 34,290

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other creditors 18,000 18,000

ACT MEDICAL LIMITED (REGISTERED NUMBER: 13638972)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2024 2023
£    £   
Within one year 32,886 11,160
Between one and five years 43,848 15,945
76,734 27,105

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1,442,419 Ordinary 0.01p 144 144

10. RELATED PARTY DISCLOSURES

There were no material related party transactions which were not concluded under normal market conditions.